| Literature DB >> 9496807 |
D W Mai1, C Omohundro, J W Dijkstra, P L Bailin.
Abstract
A significant proportion of vitiligo patients are children. Systemic PUVA therapy, the most consistently effective and practical therapy for this disease, has not been recommended in pediatric patients because of concerns regarding potential long-term side effects. We report a 9-year-old Caucasian girl with progressive vitiligo who was successfully treated with bath PUVA. This form of PUVA therapy may provide a wider margin of safety, in that less exposure to ultraviolet A (UVA) radiation is required and systemic absorption of psoralen is minimal.Entities:
Mesh：
Year: 1998 PMID： 9496807 DOI： 10.1046/j.1525-1470.1998.1998015053.x
Source DB: PubMed Journal: Pediatr Dermatol ISSN： 0736-8046 Impact factor: 1.588